Nitec Pharma AG
Medicines to treat chronic inflammation and pain-related diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
$10.0m | Series A | ||
$26.0m | Series B | ||
N/A | Acquisition | ||
| Total Funding | CAD49.1m | ||
Recent News about Nitec Pharma AG
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.